SCHEMBL31323863

SCHEMBL31323863

CN(CCCCO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C)C(CCCCC(=O)OC1CCCCCCCCCCCCCC1)CCCCC(=O)OC1CCCCCCCCCCCCCC1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NAAA Q02083 2/20 0.37
▸ CHRM2 P08172 5/20 0.37
▸ CHRM4 P08173 5/20 0.37
▸ CHRM1 P11229 5/20 0.37
▸ CHRM3 P20309 5/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ POLB P06746 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ LNPEP Q9UIQ6 1/20 0.31
▸ CYP19A1 P11511 1/20 0.31
▸ CACNA1B Q00975 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31323834 0.90 NAAA (0.40) NAAACHRM2CHRM4CHRM1CHRM3
SCHEMBL31323958 0.84 CHRM2 (0.40) CHRM2CHRM4CHRM1CHRM3SMN1; SMN2
SCHEMBL31323862 0.83 CHRM2 (0.40) CHRM2CHRM4CHRM1CHRM3SMN1; SMN2
SCHEMBL31323813 0.83 CHRM2 (0.41) CHRM2CHRM4CHRM1CHRM3SMN1; SMN2
SCHEMBL31323820 0.83 CHRM2 (0.41) CHRM2CHRM4CHRM1CHRM3SMN1; SMN2
SCHEMBL31323833 0.83 NAAA (0.38) NAAASMN1; SMN2CYP3A4HTTALDH1A1
SCHEMBL30837981 0.81 TLR2 (0.32) CHRM2CHRM4CHRM1CHRM3
SCHEMBL31323856 0.79 CHRM2 (0.36) CHRM2CHRM4CHRM1CHRM3SMN1; SMN2
SCHEMBL31323874 0.78 CHRM2 (0.38) CHRM2CHRM4CHRM1CHRM3SMN1; SMN2
SCHEMBL31323837 0.78 CHRM2 (0.38) CHRM2CHRM4CHRM1CHRM3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025035202-A1 IONIZABLE LIPIDS COMPRISING MACROCYCLIC RINGS FOR THE DELIVERY OF THERAPEUTIC AGENTS NANOVATION THERAPEUTICS INC. (CA) 2025-02-20 — — WO disclosed
Send feedback